The most gripping moment for me was quite private after my spouse suggested that we don our COVID masks and join some 5000 others at City Hall on day 6 of Seattle’s demonstrations against police violence against black people, and for massive systemic change. We were sitting on the curb during a break in the action. We were quite aware of how little we know and understand, even with the mentoring of a 24-year-old daughter who is hypersensitive to race issues. We leaned in close to each other as the mixed crowd of humans, nearer our daughter’s age than to our own, milled about. The course of our conversation led us to try to imagine needing to have had “the conversation” 15 or 20 years ago with our now 28 year old son, were we black, and he a young black man coming of age. That being his ritual welcome into adulthood.
News feeds for the natural products and integrative health practitioner fields have in recent weeks included a drumbeat of alerts on actions of the Food and Trade Commission (FTC) on what the agency considers inappropriate claims relative to COVID-19. A major natural health organization blasted the FTC’s efforts as practitioner gagging and censorship and is mounting a campaign to stop the activity. Others in these fields point to bullseyes some practitioners and companies have painted on their foreheads via gross over claims (“this mushroom will cure your COVID”) that laser-guide FTC’s actions. At a sober center amidst a tangle of issues – state/federal jurisdiction, free speech, provider-patient relationship, and the peculiar institution of in-office sales of natural products – sit Laura Farr and Rob Kachko, ND. They are the executive director and president, respectively, of the American Association of Naturopathic Physicians (AANP). Among the multiple questions is whether naturopathic doctors and others in integrative medicine are “canaries in the coal mine” of a new, potentially widening push by the FTC and other federal and state agencies into the regulation of integrative and functional medicine practitioner offices.
The paradigm-exploring brilliance of the “whole person health” focus National Center for Complementary and Integrative Health (NCCIH) director Helene Langevin, MD chose to kick off public comments on the agency’s 2021-2026 Strategic Plan sneaks up on you. In her virtual keynote, Langevin engages her audience with a fireside chat type conversational tone. She shares concepts under consideration since she left the directorship of the Harvard Osher Center for Integrative Medicine for her NIH post 17 months ago. The highly-regarded basic science researcher starts, indeed, with basics. She shares that she and her staff are re-examining what they mean by the key words like “complementary” and “health” in the agency’s name. One slowly realizes that Langevin is quietly opening what may be the most significant exploration that the $33-billion NIH should be engaging in the present era in which even an acute challenge like COVID-19 reminds us is fundamentally damaged by chronic disease.
On May 4, 2020, the Africa office of the World Health Organization (WHO) issued a statement on COVID-19 deeply at odds with policies in Europe and North America. Of the hundreds of millions of dollars with which governments and foundations are spending on research, virtually nothing is directed toward potential traditional, complementary and integrative contributions. Media coverage of the widespread interest in such approaches, when it occurs, focuses on extremes. The Wall Street Journal led with cow dung, garlic and prayer and Nature with “cow urine, bleach and cocaine” together with the broadly dismissive “pseudoscience” and “bunk”. Scores upon scores of in vitro and other trials showing antiviral activity of herbs are dismissed. In contradistinction, WHO’s statement models calmness and reason. The agency calls for research while warning about over-claims. Should WHO’s integrative, inclusive statement be actively endorsed by natural health and integrative organizations?